Skip to main navigation Skip to search Skip to main content

Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

  • Matthew Gagne
  • , Barbara J. Flynn
  • , Christopher Cole Honeycutt
  • , Dillon R. Flebbe
  • , Shayne F. Andrew
  • , Samantha J. Provost
  • , Lauren McCormick
  • , Alex Van Ry
  • , Elizabeth McCarthy
  • , John Paul M. Todd
  • , Saran Bao
  • , I. Ting Teng
  • , Shir Marciano
  • , Yinon Rudich
  • , Chunlin Li
  • , Shilpi Jain
  • , Bushra Wali
  • , Laurent Pessaint
  • , Alan Dodson
  • , Anthony Cook
    • Mark G. Lewis, Hanne Andersen, Jiří Zahradník, Mehul S. Suthar, Martha C. Nason, Kathryn E. Foulds, Peter D. Kwong, Mario Roederer, Gideon Schreiber, Robert A. Seder, Daniel C. Douek

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Medicine and Dentistry